Biosensors have impacted on a vast majority of tools in clinical diagnostics and screening, and now they are swiftly becoming part of our daily life. As a crucial example, we have largely benefitted from blood glucose monitoring tools that are successfully integrated into our everyday lives, and have therefore accelerated disease/health status monitoring. In particular, chronic conditions, such as diabetes, heart disease, arthritis, cancer, asthma, and some viral infections (such as hepatitis C and HIV/AIDS), require the frequent monitoring of biomarkers, with reliable tools, facile sampling and low-power processors that can be easily performed by end-users (mostly untrained persons), without any disruptions to their routine. Recent advances in biosensing tools with emerging nanotechnological modalities and distant but supplementary fields (e.g., artificial intelligence, internet of things (IoT)) have hurdled the vast majority of challenges in the daily monitoring of chronic conditions, as well as their treatment statuses. The further integration of biosensors with novel biomarkers, such as circulating cells/cellular components, extracellular vesicles, and proteins, has paved the way to their integration into our daily life, leveraging the current status of clinical management, by allowing the efficient and ubiquitous monitoring of conditions. This Special Issue will cover the recent advances in biosensors and their applications in monitoring chronic conditions in point-of-need settings.
Dr. Fatih Inci
Prof. Dr. Adil Denizli